4-26-12-Mead Johnson Nutrition (NYSE:MJN) reported Q1 EPS of $0.82, topping estimates by $0.04.Revenues in the quarter rose 10% to $986 million, beating estimates by $9 million.Mead Johnson sees 2012 EPS $3.04-$3.14, vs. its prior guidance of $3.00-$3.10 given in late January, while estimates are for EPS of $3.12.The company added that it expects to recover U.S. market share moving through the second half.SmarTrend is bullish on shares of Mead Johnson Nutrition and our subscribers were alerted to buy on February 17, 2012 at $76.00. The stock has risen 9.3% since the alert was issued.
